Board re-refers ordinance to require point-of-sale warnings on children’s cold medicines after expert testimony and recent FDA advisory

The San Francisco Board of Supervisors on Oct. 23 re-referred to committee a proposed ordinance that would require businesses in the city to post point-of-sale warnings on cough and cold medicines intended for use in infants and children younger than 2 years (the ordinance text discussed at the meeting also referenced an expanded version for children under 6).

Supervisor Sophie Alioto-Pier presented the legislation, saying the item had been before the City Operations and Neighborhood Services Committee and noting recent developments: several manufacturers of infant cold and cough medicines had voluntarily pulled products from shelves nationwide the morning of the committee hearing, and an FDA advisory panel recommended against use of many cold and cough products in children under age 6 because they have not been…